TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysis

Abstract Objective To compare the efficacy and safety of transarterial chemoembolization (TACE) plus donafenib and immune checkpoint inhibitors (ICIs) (combination therapy) versus TACE monotherapy for intermediate hepatocellular carcinoma (HCC). Materials and methods This nationwide, multicenter, re...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Rong Ding, Xiao-Yang Xu, Rui-Bao Liu, Jun Tie, Xu-Hua Duan, Bin Xiong, Deng-Gao Yuan, Wei-Jun Fan, Lu Wang, Zhi-Qiang Wu, Jie Zheng, Hui Zhao, Chang-Long Hou, Jin-Long Song, Ben-Sheng Zhao, Xiao-Li Zhu, Yong-Jie Su, Song Wang, Guo-Wen Yin, Li Chen, Hai-Dong Zhu, Gao-Jun Teng, Bin-Yan Zhong, CHANCE2410 Investigators
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	SpringerOpen 2026-06-01
Schriftenreihe:	European Radiology Experimental
Schlagworte:	Carcinoma (hepatocellular) Chemoembolization (therapeutic) Donafenib Immune checkpoint inhibitors Prognosis
Online-Zugang:	https://doi.org/10.1186/s41747-026-00748-5
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!